Cancer Options

Consultancy, Research and Coaching

Local number : 01623 255081 International : +44 1623 255081 Call Us Today! Make an Appointment
  • Home
  • About Us
    • Patricia Peat
      • ‘My Heroes’
    • Testimonials
  • Consultations
  • Functional Testing
  • Contact
  • FAQs
  • Downloads

Radiation therapy to treat uterine cancer linked to increased risk of bladder cancer later in life

Radiation therapy used to treat uterine cancer may increase a patient’s risk of developing bladder cancer. That is the conclusion of a recent study published in BJU International. The findings indicate the importance of monitor-ing patients for potential signs of bladder cancer to ensure early diagnosis and treatment.

In the United States, uterine cancer is the fourth most common cancer in women, with an estimated 49,560 women diagnosed in 2013. In addition to surgery, 38 percent of patients undergo pelvic radiation therapy to de-crease uterine cancer recurrence. Studies have found that women treated with radiation therapy for uterine can-cer, like men who received radiation therapy for prostate cancer, have an increased risk of developing bladder cancer later in life.

To investigate the issue, Guan Wu, MD, PhD, of the University of Rochester Medical Center, and his colleagues analyzed the records of 56,681 patients diagnosed with uterine cancer as their first primary malignancy between 1980 and 2005. The information was obtained from the Surveillance, Epidemiology and End-Results (SEER) data-base.

With an average follow-up of 15 years, bladder cancer incidence in uterine cancer patients treated with pelvic radiation therapy was twice as high as that seen in patients treated without radiation. Similarly, the death rate from bladder cancer was nearly three times higher in patients treated with pelvic radiation than in those who did not receive radiation. It is commonly thought that bladder cancers that develop after pelvic radiation tend to be aggressive, with high grades and stages, but this study found that the types, grades, and stages of bladder cancer that developed were similar in patients treated with and without radiation therapy.

“Physicians who care for patients with a history of uterine cancer and pelvic radiation treatment should keep in mind the increased risk of bladder cancer,” said Dr. Wu. “Proper clinical evaluation should be performed to avoid delayed diagnosis, which may improve the quality of care for this group of patients.”

Filed Under: Cancer Therapies, Detoxification, Drug Development, Holistic Developments, Nutrition Research

Register Now for more Updates
and Upgrades!

PREPARE SUPPORT RECOVER

PREPARE : - The environment surrounding cancer cells can help cells resist treatment and develop resistance. Alter that environment by fasting, reducing inflammation, boosting immune cells to prepare the environment to get the best effects from treatment

SUPPORT : - Minimise side effects, maintain a functioning immune system, support depleted nutritional status, reduce fatigue

RECOVER : - Quickly and effectively, oxygenate, check underlying damage and imbalances, repair, set up ongoing monitoring and assessment, move on!

GET SOCIAL

Follow me on Twitter

Tweets by @PatriciaPeat

About Us

CancerOptions is a private cancer consultancy working at the forefront of cancer treatment developments around the world.

We offer a range of services including:

  • tailored nutritional programmes
  • one-on-one consultations
  • news, information and resources about cutting-edge treatments around the world
  • advice & support on staying healthy during and after cancer treatment
  • coaching for medical and other healthcare professionals

Quick Links

  • Home
  • About Us
    • Patricia Peat
      • ‘My Heroes’
    • Testimonials
  • Consultations
  • Functional Testing
  • Contact
  • FAQs
  • Downloads

Contact Information

P | 01623 255081

E | patricia@canceroptions.co.uk

W | canceroptions.co.uk

Copyright © 2016 Cancer Option Ltd. All Rights Reserved Privacy Policy | Disclaimer